WebPreoperative chemotherapy with S-1 + CDDP followed by gastrectomy is a safe and promising treatment for type 4 and large type 3 gastric cancers. Based on the results of … Web【jcog0501】 根治切除可能な大型3型・4型胃癌に対する術前TS-1+CDDP併用療法による第Ⅲ相試験：主解析（安全性および手術に関する短期成績）
Gastrectomy with or without neoadjuvant S-1 plus …
Web4 apr 2024 · JCOG1509: 局所進行胃癌における術後補助化学療法に対する周術期化学療法の優越性を検証することを目的としたランダム化比較第III相試験. JCOG1509: Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally ... Web公開論文一覧. JCOG1711 漿膜下浸潤及び漿膜浸潤を伴う進行胃癌を対象とした大網切除に対する大網温存の非劣性を検証するランダム化比較試験. Sato Y, Yamada T, Yoshikawa T, et al. Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric ... brainy 4 test 1-4
総括報告書 JCOG0405： 高度リンパ節転移を伴う進行胃がんに対 …
Web28 mar 2024 · Subgroup analysis of JCOG0501 phase III study to confirm superiority of additional neoadjuvant chemotherapy with S-1 plus cisplatin to D2 gastrectomy with S-1 adjuvant chemotherapy for resectable type IV or large … http://www.jcog.jp/document/0501.pdf Web5 mar 2024 · JCOG0501. Based on the positive results of JCOG0210, JCOG conducted a phase III study to confirm the efficacy of NAC in patients with linitis plastica (type 4) and large (≥8 cm) ulcero-invasive-type (type 3) gastric cancer. At the time of initiating the trial, adjuvant chemotherapy with S-1 was recognized as a standard treatment. hadsor limited